MedMira Inc

NEW
STU:47M (Canada)  
€ 0.032 -0.0030 (-8.7%) Jul 9
At Loss
Market Cap:
€ 28.21M ($ 32.21M)
Enterprise V:
€ 34.29M ($ 39.16M)
Volume:
0
Avg Vol (2M):
56.62K
Trade In:

Business Description

Description
MedMira Inc is a biotechnology company engaged in the research, development, and manufacturing of rapid diagnostics and technologies. The company operates in one reportable operating segment, rapid diagnostic products and services. Its product line includes HIV, COVID-19, syphilis, Multiplex, Miriad RVF Toolkit, and H. pylori. The company generates revenue from North America, Europe, and other regions, with the majority generated from North America.

Financial Strength

Name Current Vs Industry Vs History
Equity-to-Asset
-7.21
Debt-to-Equity
-0.4
Debt-to-EBITDA
-5.91
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-53.6
Distress
Grey
Safe
Beneish M-Score
-5.68
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
30.41
9-Day RSI
41.06
14-Day RSI
45.6
3-1 Month Momentum %
1.59
6-1 Month Momentum %
-13.51
12-1 Month Momentum %
-20

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.06
Quick Ratio
0.05
Days Inventory
724.38
Days Sales Outstanding
1288.22
Days Payable
10672.04

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-0.2
Shareholder Yield %
-0.63

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin %
71.97
Operating Margin %
-530.73
Net Margin %
-807.55
EBITDA Margin %
-448.79
FCF Margin %
-322.17
OCF Margin %
-322.17
ROA %
-83.07
ROIC %
-11.82
3-Year ROIIC %
-37.97
ROC (Joel Greenblatt) %
-98.03
Moat Score
3
Tariff Resilience Score
5

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT
-28.17
EV-to-EBITDA
-33.3
EV-to-Revenue
149.44
EV-to-FCF
-46.55
Earnings Yield (Greenblatt) %
-3.55
FCF Yield %
-2.61

Financials

STU:47M's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

MedMira Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.23
EPS (TTM) (€) -0.004
Beta 0.3235
3-Year Sharpe Ratio -0.14
3-Year Sortino Ratio -0.27
Volatility % 43.57
14-Day RSI 45.6
14-Day ATR (€) 0.003405
20-Day SMA (€) 0.034025
12-1 Month Momentum % -20
52-Week Range (€) 0.0265 - 0.0555
Shares Outstanding (Mil) 701.73

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

MedMira Inc Filings

Filing Date Document Date Form
No Filing Data

MedMira Inc Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

MedMira Inc Frequently Asked Questions

What is MedMira Inc(STU:47M)'s stock price today?
The current price of STU:47M is €0.03. The 52 week high of STU:47M is €0.06 and 52 week low is €0.03.
When is next earnings date of MedMira Inc(STU:47M)?
The next earnings date of MedMira Inc(STU:47M) is .
Does MedMira Inc(STU:47M) pay dividends? If so, how much?
MedMira Inc(STU:47M) does not pay dividend.

Articles on MedMira Inc

No articles.